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The plural of ‘anecdote’ is not ‘fact’ 1 
 
Avian, and particularly reptile, medicine are relatively new fields of veterinary 
medicine. As such, the associated learning curves are steep and exponential, 
and those who practise in these fields display an admirable thirst for new 
knowledge. This is evidenced by: 
 
 Journals dedicated to these species e.g. the Journal of Avian Medicine 
and Surgery, the Journal of Herpetological Medicine and Surgery, and 
Veterinary Clinics of North America: Exotic Animal Practice; 
 Textbooks such as Clinical Avian Medicine and Surgery and Medicine 
and Surgery of Reptiles; 
 Internet discussion forums, such as the Unusual and Exotic Pets 
Veterinary SIG, Exotic DVM, Birdmed, and VIN; 
 Conferences 
 
The advent of the Internet has allowed the free and rapid passage of information 
between veterinarians around the globe. Unfortunately, the lack of adequately 
funded scientific research has meant that much of the information disseminated 
between veterinarians is anecdotal – see one, do one, teach…While some of 
this information is indeed factual and at the cutting edge of veterinary medicine, 
an equal (or greater) amount is incorrect, misleading and potentially dangerous.  
 
If we are to continue to advance avian and reptile medicine to the highest levels, 
it is vital that we be able to distinguish between scientifically valid information 
and unproven anecdotes. This is where Evidence Based Medicine (EBM) comes 
into play. 
 
What is EBM? 
EBM is “the conscientious, explicit and judicious use of current best evidence in 
making decisions about the care of individual patients”; it involves the integration 
of clinical expertise and the systematic research of externally available clinical 
evidence. At its core is our confidence in scientific methodology enabling us to 
distinguish between information that is likely to be accurate and that which is 
likely to be false or unproven. 2  
 
When faced with a complicated and challenging case a clinician can choose to 
work it up using one of two approaches: an educated guess (using pattern 
recognition, assumptions about disease epidemiology and pathophysiology, 
consulting colleagues in person or on the ‘Net, and browsing journals, 
conference proceedings and even lay literature); or EBM to systematically and 
scientifically evaluate the available evidence, thereby eliminating the effects of 
memory, assumptions, and personal bias.  
 
Some examples where EBM was not – but should have been - used 
In last few decades there have been a few ‘accepted truths’ in avian and reptile 
medicine that were based on anecdotal evidence, extrapolated from mammalian 
medicine, or arose from a misunderstanding of physiology. EBM has disproved 
these ‘truths’ in recent years, yet they are still accepted as truths by many 
clinicians.  
 
Lactulose is often recommended as a treatment for liver disease in parrots, 
especially in some on-line forums. This recommendation appears to have been 
extrapolated from mammalian medicine, where the action of lactulose in the 
intestinal lumen may reduce the amount of ammonia presented to the liver via 
portal circulation, and reduces the risk of hepatoencephalopathy.  Lactulose 
does not have any direct effect on the liver. The recommendation for the use of 
lactulose in parrots does not appear to take into account that vegetable proteins 
have minimal encephalopathic precursors and that hepatoencephalopathy has 
not been documented in parrots. Yet many treatment recommendations for liver 
disease in parrots include the use of lactulose, despite the complete lack of peer-
reviewed evidence of its efficacy.  
 
It is frequently recommended that reptiles and birds not be injected with drugs in 
the caudal part of the body, in case the renal portal valve system allows the drug 
to be excreted rather than entering general circulation. This recommendation 
ignores that this valve is adrenergic in its response, and that the stress of being 
handled and injected would open the valve and the drug would enter general 
circulation before entering the renal circulation. This was borne out by Holz’s 
work (2002). 3 Despite this, the recommendation continues to be made in 
veterinary literature. 
 
Calcium disodium versenate (Ca EDTA), used for treating heavy metal toxicosis, 
is widely reported to be nephrotoxic and care is urged in its use. This extends to 
a common recommendation to use it for 3-5 days on, and then 3-5 days off; this 
cycle is repeated until the patient reaches acceptable blood levels of the toxin in 
question. Following the literature trail back to the origin of this recommendation, 
the source appears to be a single paper reporting nephrotoxicosis in a group of 
lead-affected children treated with Ca EDTA. This paper made no attempt to 
distinguish between damage caused to the kidneys by the lead or by the drug 
(Alan Fudge, personal communication). Yet this paper is still the primary source 
for the treatment recommendation for lead poisoning in many different species – 
including birds.  
 
Zinc toxicosis is possibly the most over-diagnosed condition in avian medicine 
today, with almost every conceivable medical condition laid at its door - feather-
picking, poor growth, neurological disease, and so on. Much of this ‘zinc hysteria’ 
can be attributed to a non-peer reviewed paper presented at an Association of 
Avian Veterinarians conference, and subsequently repeated in lay literature. This 
paper ignored much of the known knowledge of the physiology of zinc and its 
effects as a toxin, and the ongoing ‘zinc myth’ continues to ignore the many 
subsequent papers discussing zinc and its toxic effects. One can only speculate 
how many clients have spent money for zinc testing – and how many patients 
have needlessly been treated for zinc toxicosis - when EBM suggests this testing 
is unnecessary. 
 
These are just some of the recommendations made on the Internet and in 
veterinary literature. The overwhelming feature of these recommendations 
appears to be their blanket acceptance by much of the veterinary community as 
being factual, without any attempt at scientific validatation. It is the author’s 
opinion that this blanket acceptance is hindering the progression of avian and 
reptile medicine.   
 
 
So how do we use EBM? 
EBM requires a large body of high quality, patient-centred research that is 
readily available to veterinarians who are able to access and critically appraise 
the data. 2 
 
One of the biggest hurdles to the widespread use of EBM in veterinary medicine 
today is the lack of ‘methodically performed, rigorous, large-scale studies in 
veterinary medicine.2 As avian and reptile practitioners, we must recognise that 
this deficit is particularly glaring in our field. There is a pressing need in our field 
to compile data from clinical experience and publish it, after subjecting it to peer-
review, so that we can expand the available knowledge database. Australian 
universities have limited funds available – and perhaps limited interest – for 
conducting large scale trials. This, in effect, throws the burden – the 
responsibility, if you like – for compiling this data onto the shoulders of private 
practitioners.  
 
As we expand this database, the next step is for clinicians to use it in their 
decision-making process. Cockcroft and Holmes (2003)2 suggest that the 
following self-assessment can indicate to a clinician if they are already practising 
EBM: 
 
 Do I identify and prioritise the problems to be solved (information needs)? 
 Do I perform a competent and complete examination to establish the 
likelihood of alternative diagnoses? 
 Do I have an accurate knowledge of disease manifestations, the sign 
sensitivities and specificities, and the frequency of occurrence of different 
combinations of clinical signs within a disease(s)? 
 Do I search for the missing information? 
 Do I appraise the information in terms of scientific validity? 
 Do I understand the scientific terms such as sensitivity and specificity, 
which will enable me to interpret the information provided? 
 Do I have the resources to access the Internet? 
 Am I aware of the veterinary information databases? 
 Am I aware of the veterinary decision support systems that are available? 
 Is the application of new information scientifically justified, and intuitively 
sensible, for this situation? 
 Do I explain the pros and cons of the differing opinions, taking into 
account the different utilities, to the owners? 
 
What do I get out of EBM? 
Utilised well, EBM will allow the clinician to reach an accurate diagnosis; to form 
a well-considered prognosis; to decide on the best treatment plan; and to 
formulate prevention and control plans. All of these objectives go towards one 
primary objective – the welfare of our patient. 
 
So what skills do I need to develop to practice EBM? 
Many of us feel that we already practice EBM, but the self-assessment questions 
above may lead you to recognise areas of deficiency that need to be worked on. 
New skills must be learnt – or perhaps, re-learnt. These include: 
 
 The need to convert information needs into clinical questions that must 
be answered; 
 The identification of sources of information, and learning how to search 
these for the answers we need; 
 Learning how to appraise this information critically and scientifically so as 
to validate its application to the current problem; 
 Using this now-validated information to formulate a diagnosis and 
treatment plan.  
 
These skills do not come naturally to us, but they are skills we need to develop if 
we are to take avian and reptile medicine to the next level and beyond.  
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